Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
about
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn's Disease Treated with Adalimumab or Infliximab.Variation in inflammatory bowel disease care among saudi pediatric gastroenterologists.Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.The biologics of ulcerative colitis.Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab-treated patients.Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.Therapeutic drug monitoring was helpful in guiding the decision-making process for children receiving infliximab for inflammatory bowel disease.Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database
P2860
Q37373219-FA21354F-C082-448E-B4AD-0A550246721DQ37671228-FD349DF0-51DE-4D07-B9B1-89BE0045B700Q38850063-2DCEBABF-2BE4-46BE-97EA-459F6FDC49D4Q38950429-427C4BA8-39C6-46A0-8F42-3AC5AAA06D4CQ39037681-7F7333B1-1C94-46C6-840F-E01394151097Q39353122-80B91B8C-8163-49AD-B19F-7025A8DEDBF0Q47624995-843FC091-3D19-44DC-AE60-6A377FA0AD99Q48230305-DB36D55C-524E-424B-ADDF-3A9BDB2C29C8Q53772990-E5423E3D-8213-445A-8BFA-C96BC31C84ECQ57074034-09A0FAD4-FAE3-4C3F-956F-116BC40FDC4F
P2860
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
@en
type
label
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
@en
prefLabel
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
@en
P2093
P2860
P921
P356
P1476
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
@en
P2093
Catherine Reenaers
Edouard Louis
Julia Salleron
Jérôme Filippi
Ophélie Antunes
Virginie Filipe
Xavier Hébuterne
Xavier Roblin
P2860
P304
P356
10.1093/ECCO-JCC/JJW008
P577
2016-01-22T00:00:00Z